ABC01037IX

Ombitasvir

Ombitasvir (CAS 1258226-87-7) is a next-generation NS5A inhibitor featuring a fused bicyclic naphthyridine core linked to a substituted piperazine moiety via an amide bond. Its structure incorporates a 4-aminophenyl ether side chain and a 2-aminothiazole subunit, conferring high target specificity. As the parent drug, it directly mediates antiviral activity through NS5A replication complex inhibition. This compound serves as an HPLC reference standard for quantification in fixed-dose combination therapies.

On Request
Molecular Formula C50H67N7O8
Molecular Weight 894.1000
CAS Number 1258226-87-7 ✓ Verified
PubChem CID 54767916 ↗
Purity N/A
Product Type API
Parent Drug Ombitasvir
Lead Time On Request
IUPAC Name methyl N-[(2S)-1-[(2S)-2-[[4-[(2S,5S)-1-(4-tert-butylphenyl)-5-[4-[[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidine-2-carbonyl]amino]phenyl]pyrrolidin-2-yl]phenyl]carbamoyl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate

📝 Synonyms

Ombitasvir 1258226-87-7 ABT-267 ABT267 CHEBI:85183 ABT 267 2302768XJ8 DTXSID201027920 VIEKIRAX COMPONENT OMBITASVIR Carbamic acid, N,N'-(((2S,5S)-1-(4-(1,1-dimethylethyl)phenyl)-2,5-pyrrolidinediyl)bis(4,1-phenyleneiminocarbonyl-(2S)-2,1-pyrrolidinediyl((1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl)))bis-, C,C'-dimethyl ester

🔬 Chemical Identifiers

CC(C)[C@@H](C(=O)N1CCC[C@H]1C(=O)NC2=CC=C(C=C2)[C@@H]3CC[C@H](N3C4=CC=C(C=C4)C(C)(C)C)C5=CC=C(C=C5)NC(=O)[C@@H]6CCCN6C(=O)[C@H](C(C)C)NC(=O)OC)NC(=O)OC
InChI=1S/C50H67N7O8/c1-30(2)42(53-48(62)64-8)46(60)55-28-10-12-40(55)44(58)51-35-20-14-32(15-21-35)38-26-27-39(57(38)37-24-18-34(19-25-37)50(5,6)7)33-16-22-36(23-17-33)52-45(59)41-13-11-29-56(41)47(61)43(31(3)4)54-49(63)65-9/h14-25,30-31,38-43H,10-13,26-29H2,1-9H3,(H,51,58)(H,52,59)(H,53,62)(H,54,63)/t38-,39-,40-,41-,42-,43-/m0/s1
PIDFDZJZLOTZTM-KHVQSSSXSA-N

Related Products